$PHLT
Performant Healthcare Inc Stock $phlt

$phlt Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000155069518000006 Filed on March 14, 2018

Income Statement

Concept	2017 Q4	2016 Q4	2015 Q4
Revenue	$33.29M	$33.81M	$41.05M
YoY Change	-1.54%	-17.64%	3.4%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$20.55M	$18.76M	$20.48M
YoY Change	9.54%	-8.4%	-8.73%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.510M	$3.280M	$3.040M
YoY Change	-23.48%	7.89%	-10.32%
% of Gross Profit
Operating Expenses	$33.40M	$33.34M	$36.28M
YoY Change	0.18%	-8.1%	-10.57%
Operating Profit
YoY Change
Interest Expense	-$1.290M	-$1.760M	-$2.090M
YoY Change	-26.7%	-15.79%	-13.28%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.470M	-$16.73M	$2.690M
YoY Change	-85.24%	-721.93%	-182.01%
Income Tax	-$2.990M	-$4.430M	$490.0K
% Of Pretax Income			18.22%
Net Earnings	$520.0K	-$12.30M	$2.200M
YoY Change	-104.23%	-659.09%	-192.44%
Net Earnings / Revenue	1.56%	-36.38%	5.36%
Basic Earnings Per Share
Diluted Earnings Per Share	$10.19K	-$244.9K	$44.46K
COMMON SHARES
Basic Shares Outstanding	50.96M shares	50.23M shares	49.48M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q4	2016 Q4	2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.70M	$33.00M	$71.20M
YoY Change	-34.24%	-53.65%	-11.33%
Cash & Equivalents	$21.73M	$32.98M	$71.18M
Short-Term Investments
Other Short-Term Assets	$14.50M	$25.50M	$20.10M
YoY Change	-43.14%	26.87%	-5.19%
Inventory
Prepaid Expenses
Receivables	$12.50M	$11.50M	$18.00M
Other Receivables	$6.800M	$2.000M	$0.00
Total Short-Term Assets	$55.53M	$72.01M	$109.3M
YoY Change	-22.89%	-34.09%	-9.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$20.94M	$23.74M	$25.52M
YoY Change	-11.76%	-6.98%	-7.71%
Goodwill	$81.57M	$82.52M	$82.52M
YoY Change	-1.15%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.500M	$900.0K	$200.0K
YoY Change	66.67%	350.0%	-92.59%
Total Long-Term Assets	$108.9M	$113.1M	$133.3M
YoY Change	-3.68%	-15.17%	-6.09%
TOTAL ASSETS
Total Short-Term Assets	$55.53M	$72.01M	$109.3M
Total Long-Term Assets	$108.9M	$113.1M	$133.3M
Total Assets	$164.4M	$185.1M	$242.5M
YoY Change	-11.15%	-23.69%	-7.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.518M	$628.0K	$929.0K
YoY Change	141.72%	-32.4%	-32.19%
Accrued Expenses	$4.600M	$4.300M	$4.800M
YoY Change	6.98%	-10.42%	-11.11%
Deferred Revenue	$0.00
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.029M	$9.700M	$8.000M
YoY Change	-79.08%	21.25%	-18.37%
Total Short-Term Liabilities	$43.08M	$51.47M	$53.72M
YoY Change	-16.3%	-4.18%	-3.66%
LONG-TERM LIABILITIES
Long-Term Debt	$38.56M	$43.90M	$84.10M
YoY Change	-12.18%	-47.8%	-17.55%
Other Long-Term Liabilities	$2.476M	$2.356M	$2.006M
YoY Change	5.09%	17.45%	-11.2%
Total Long-Term Liabilities	$84.11M	$98.83M	$148.7M
YoY Change	-14.9%	-33.53%	-13.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$43.08M	$51.47M	$53.72M
Total Long-Term Liabilities	$84.11M	$98.83M	$148.7M
Total Liabilities	$84.11M	$98.83M	$148.7M
YoY Change	-14.9%	-33.53%	-34.62%
SHAREHOLDERS EQUITY
Retained Earnings	$7.861M	$20.59M	$32.04M
YoY Change	-61.82%	-35.74%	-5.3%
Common Stock	$72.46M	$65.66M	$61.81M
YoY Change	10.37%	6.22%	7.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$80.33M	$86.25M	$93.86M
YoY Change
Total Liabilities & Shareholders Equity	$164.4M	$185.1M	$242.5M
YoY Change	-11.15%	-23.69%	-7.72%

Cashflow Statement

Concept	2017 Q4	2016 Q4	2015 Q4
OPERATING ACTIVITIES
Net Income	$520.0K	-$12.30M	$2.200M
YoY Change	-104.23%	-659.09%	-192.44%
Depreciation, Depletion And Amortization	$2.510M	$3.280M	$3.040M
YoY Change	-23.48%	7.89%	-10.32%
Cash From Operating Activities	$2.200M	-$2.710M	-$2.840M
YoY Change	-181.18%	-4.58%	-244.9%
INVESTING ACTIVITIES
Capital Expenditures	-$1.850M	-$2.340M	-$2.260M
YoY Change	-20.94%	3.54%	-34.11%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$1.850M	-$2.340M	-$2.270M
YoY Change	-20.94%	3.08%	-33.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-20.00K	-2.770M	-2.020M
YoY Change	-99.28%	37.13%	-37.07%
NET CHANGE
Cash From Operating Activities	2.200M	-2.710M	-2.840M
Cash From Investing Activities	-1.850M	-2.340M	-2.270M
Cash From Financing Activities	-20.00K	-2.770M	-2.020M
Net Change In Cash	330.0K	-7.820M	-7.130M
YoY Change	-104.22%	9.68%	52.35%
FREE CASH FLOW
Cash From Operating Activities	$2.200M	-$2.710M	-$2.840M
Capital Expenditures	-$1.850M	-$2.340M	-$2.260M
Free Cash Flow	$4.050M	-$370.0K	-$580.0K
YoY Change	-1194.59%	-36.21%	-110.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0001550695
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	51360328	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2017Q2	dei	Entity Public Float EntityPublicFloat	54592098	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	Performant Financial Corporation
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2017	dei	Trading Symbol TradingSymbol	PFMT
CY2017Q3	pfmt	Debt Instrument Convertible Numberof Optional Additional Extension Periods DebtInstrumentConvertibleNumberofOptionalAdditionalExtensionPeriods	2	extension_period
CY2016Q4	pfmt	Deferred Tax Assets Acquisition Costs DeferredTaxAssetsAcquisitionCosts	66000	USD
CY2017Q4	pfmt	Deferred Tax Assets Acquisition Costs DeferredTaxAssetsAcquisitionCosts	23000	USD
CY2016Q4	pfmt	Deferred Tax Assets Debt Issuance Costs DeferredTaxAssetsDebtIssuanceCosts	279000	USD
CY2017Q4	pfmt	Deferred Tax Assets Debt Issuance Costs DeferredTaxAssetsDebtIssuanceCosts	27000	USD
CY2017Q4	pfmt	Deferred Tax Assets Federal Taxes DeferredTaxAssetsFederalTaxes	300000	USD
CY2016Q4	pfmt	Deferred Tax Assets Nonqualified Stock Options DeferredTaxAssetsNonqualifiedStockOptions	4893000	USD
CY2017Q4	pfmt	Deferred Tax Assets Nonqualified Stock Options DeferredTaxAssetsNonqualifiedStockOptions	3917000	USD
CY2017Q3	pfmt	Durationof Optional Additional Extension Periods DurationofOptionalAdditionalExtensionPeriods	P1Y
CY2015	pfmt	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.09
CY2016	pfmt	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.01
CY2017	pfmt	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	0.01
CY2015	pfmt	Effective Income Tax Rate Reconciliation Work Opportunity Credit Percent EffectiveIncomeTaxRateReconciliationWorkOpportunityCreditPercent	0.09
CY2016	pfmt	Effective Income Tax Rate Reconciliation Work Opportunity Credit Percent EffectiveIncomeTaxRateReconciliationWorkOpportunityCreditPercent	0.01
CY2017	pfmt	Effective Income Tax Rate Reconciliation Work Opportunity Credit Percent EffectiveIncomeTaxRateReconciliationWorkOpportunityCreditPercent	0.02
CY2017Q4	pfmt	Estimated Litigation Liability Healthcare Contracts Current EstimatedLitigationLiabilityHealthcareContractsCurrent	300000	USD
CY2015	pfmt	Excess Tax Benefit Shortfallfrom Sharebased Compensation Financing Activities ExcessTaxBenefitShortfallfromSharebasedCompensationFinancingActivities	20000	USD
CY2015	pfmt	Excess Tax Benefit Shortfallfrom Sharebased Compensation Financing Activities ExcessTaxBenefitShortfallfromSharebasedCompensationFinancingActivities	22000	USD
CY2016	pfmt	Excess Tax Benefit Shortfallfrom Sharebased Compensation Financing Activities ExcessTaxBenefitShortfallfromSharebasedCompensationFinancingActivities	100000	USD
CY2016	pfmt	Excess Tax Benefit Shortfallfrom Sharebased Compensation Financing Activities ExcessTaxBenefitShortfallfromSharebasedCompensationFinancingActivities	103000	USD
CY2017	pfmt	Excess Tax Benefit Shortfallfrom Sharebased Compensation Financing Activities ExcessTaxBenefitShortfallfromSharebasedCompensationFinancingActivities	0	USD
CY2017	pfmt	Excess Tax Benefit Shortfallfrom Sharebased Compensation Financing Activities ExcessTaxBenefitShortfallfromSharebasedCompensationFinancingActivities	0	USD
CY2015	pfmt	Increase Decreasein Estimated Liability For Appeals IncreaseDecreaseinEstimatedLiabilityForAppeals	493000	USD
CY2016	pfmt	Increase Decreasein Estimated Liability For Appeals IncreaseDecreaseinEstimatedLiabilityForAppeals	187000	USD
CY2017	pfmt	Increase Decreasein Estimated Liability For Appeals IncreaseDecreaseinEstimatedLiabilityForAppeals	-488000	USD
CY2015	pfmt	Interest Expense Debt Issuance Costs And Amortization InterestExpenseDebtIssuanceCostsAndAmortization	1242000	USD
CY2016	pfmt	Interest Expense Debt Issuance Costs And Amortization InterestExpenseDebtIssuanceCostsAndAmortization	1264000	USD
CY2017	pfmt	Interest Expense Debt Issuance Costs And Amortization InterestExpenseDebtIssuanceCostsAndAmortization	1336000	USD
CY2015	pfmt	Number Of Single Customers Comprising More Than Ten Percent Of Consolidated Net Sales NumberOfSingleCustomersComprisingMoreThanTenPercentOfConsolidatedNetSales	3	Customer
CY2016	pfmt	Number Of Single Customers Comprising More Than Ten Percent Of Consolidated Net Sales NumberOfSingleCustomersComprisingMoreThanTenPercentOfConsolidatedNetSales	3	Customer
CY2017	pfmt	Number Of Single Customers Comprising More Than Ten Percent Of Consolidated Net Sales NumberOfSingleCustomersComprisingMoreThanTenPercentOfConsolidatedNetSales	2	Customer
CY2016Q4	pfmt	Other Assets Net OtherAssetsNet	914000	USD
CY2017Q4	pfmt	Other Assets Net OtherAssetsNet	1058000	USD
CY2016Q4	pfmt	Other Assets Subcontractor Receivables Already Overturned Audits OtherAssetsSubcontractorReceivablesAlreadyOverturnedAudits	3700000	USD
CY2017Q4	pfmt	Other Assets Subcontractor Receivables Already Overturned Audits OtherAssetsSubcontractorReceivablesAlreadyOverturnedAudits	3700000	USD
CY2016Q4	pfmt	Other Assets Subcontractor Receivables Future Overturned Audits OtherAssetsSubcontractorReceivablesFutureOverturnedAudits	5700000	USD
CY2017Q4	pfmt	Other Assets Subcontractor Receivables Future Overturned Audits OtherAssetsSubcontractorReceivablesFutureOverturnedAudits	5600000	USD
CY2015	pfmt	Payment Of Purchase Obligation PaymentOfPurchaseObligation	1123000	USD
CY2016	pfmt	Payment Of Purchase Obligation PaymentOfPurchaseObligation	554000	USD
CY2017	pfmt	Payment Of Purchase Obligation PaymentOfPurchaseObligation	0	USD
CY2015	pfmt	Repayments Of Long Term Notes Payable RepaymentsOfLongTermNotesPayable	17537000	USD
CY2016	pfmt	Repayments Of Long Term Notes Payable RepaymentsOfLongTermNotesPayable	39076000	USD
CY2017	pfmt	Repayments Of Long Term Notes Payable RepaymentsOfLongTermNotesPayable	55513000	USD
CY2017	pfmt	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Company Weighting Comparable Peer Companies ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateCompanyWeightingComparablePeerCompanies	0.88
CY2017	pfmt	Share Priceon Dateof Issuanceof Debt Equity Instrument SharePriceonDateofIssuanceofDebtEquityInstrument	1.85
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	628000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1518000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	57107000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	64395000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	65650000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	72459000	USD
CY2015	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-507000	USD
CY2016	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-963000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5009000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4713000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3740000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	3302000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5000000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4700000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3700000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	224000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	200000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	35000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3800000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3700000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	900000	USD
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4430292	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3996701	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4604218	shares
CY2016Q4	us-gaap	Assets Assets	185078000	USD
CY2017Q4	us-gaap	Assets Assets	164436000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	72012000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	55530000	USD
CY2015	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	7000000	USD
CY2016	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	6900000	USD
CY2017	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	5100000	USD
CY2015	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	4800000	USD
CY2016	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	5800000	USD
CY2017	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	6700000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32982000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21731000	USD
CY2014Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80298000	USD
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71182000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40484000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23519000	USD
CY2015	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9116000	USD
CY2016	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30698000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16965000	USD
CY2017Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.92
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2012Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50234000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51085000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50234000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51085000	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	5000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	5000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1764000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11432000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12732000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1393000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3835000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-5427000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2557000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2542000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-5058000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1164000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-1293000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	369000	USD
CY2016Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	13100000	USD
CY2016Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	13074000	USD
CY2017Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	12800000	USD
CY2017Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	12800000	USD
CY2015	us-gaap	Customer Refundable Fees Period Increase Decrease CustomerRefundableFeesPeriodIncreaseDecrease	2290000	USD
CY2016	us-gaap	Customer Refundable Fees Period Increase Decrease CustomerRefundableFeesPeriodIncreaseDecrease	-1326000	USD
CY2017	us-gaap	Customer Refundable Fees Period Increase Decrease CustomerRefundableFeesPeriodIncreaseDecrease	-274000	USD
CY2017Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	44000000	USD
CY2017Q3	us-gaap	Debt Instrument Convertible Remaining Discount Amortization Period1 DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1	P36M
CY2017Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	3416000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2578000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5379000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2643000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	1294000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	171000	USD
CY2017Q3	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	600000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	272000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	3245000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2943000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6912000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3733000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5330000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4197000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1130000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-365000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1533000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1090000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	104000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	15000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13388000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	10437000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4201000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	468000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	9531000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4665000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	5331000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	217000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	453000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	400000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	146000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	448000	USD
CY2016Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	843000	USD
CY2017Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	384000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	298000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	452000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	500000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	557000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	510000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	92000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	11000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	5585000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies	3956000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	308000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	241000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3857000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5772000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1299000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	733000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	22000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	34000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	4009000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3430000	USD
CY2015	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2016	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2015	us-gaap	Depreciation Depreciation	9300000	USD
CY2016	us-gaap	Depreciation Depreciation	9600000	USD
CY2017	us-gaap	Depreciation Depreciation	10000000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13132000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13380000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10888000	USD
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2015	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31000	USD
CY2016	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21000	USD
CY2017	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3000	USD
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.17
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.28
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.09
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.00
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.18
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.13
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.00
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.00
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.06
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.04
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.02
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.00
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.04
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.01
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.01
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.26
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.11
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.08
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4315000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4569000	USD
CY2017	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P11M5D
CY2015Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	4700000	USD
CY2016Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2000000	USD
CY2017Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	300000	USD
CY2017	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0
CY2017	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P5Y
CY2017	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.500
CY2017	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0183
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19799000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	20514000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	809000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	811000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	811000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	811000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	811000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	811000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	25694000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	25378000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5895000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4864000	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	585000	USD
CY2016	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-12000	USD
CY2017	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-67000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	82522000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	81572000	USD
CY2015	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	236000	USD
CY2016	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	15438000	USD
CY2017	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	1081000	USD
CY2017Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	900000	USD
CY2015	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	200000	USD
CY2016	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	15400000	USD
CY2017	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	100000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2181000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15823000	USD
CY2017Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	6839000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-441000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-301000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	890000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14054000	USD
CY2016Q4	us-gaap	Income Tax Examination Penalties Accrued IncomeTaxExaminationPenaltiesAccrued	0	USD
CY2017Q4	us-gaap	Income Tax Examination Penalties Accrued IncomeTaxExaminationPenaltiesAccrued	0	USD
CY2016	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	0	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-386000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4370000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1325000	USD
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-2726000	USD
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5273000	USD
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-353000	USD
CY2016Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2027000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2918000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6481000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1010000	USD
CY2015	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	895000	USD
CY2016	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-895000	USD
CY2017	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	USD
CY2015	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-619000	USD
CY2016	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-446000	USD
CY2017	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	254000	USD
CY2015	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-4394000	USD
CY2016	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	2027000	USD
CY2017	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	4812000	USD
CY2015	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1766000	USD
CY2016	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-656000	USD
CY2017	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1062000	USD
CY2015	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-174000	USD
CY2016	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	740000	USD
CY2017	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	148000	USD
CY2015	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-253000	USD
CY2016	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	350000	USD
CY2017	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	120000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	374000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-247000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-8000	USD
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2015	us-gaap	Interest Expense InterestExpense	8889000	USD
CY2016	us-gaap	Interest Expense InterestExpense	7897000	USD
CY2017	us-gaap	Interest Expense InterestExpense	6972000	USD
CY2015	us-gaap	Interest Paid InterestPaid	7650000	USD
CY2016	us-gaap	Interest Paid InterestPaid	6156000	USD
CY2017	us-gaap	Interest Paid InterestPaid	4284000	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	4000	USD
CY2015	us-gaap	Labor And Related Expense LaborAndRelatedExpense	88077000	USD
CY2016	us-gaap	Labor And Related Expense LaborAndRelatedExpense	78863000	USD
CY2017	us-gaap	Labor And Related Expense LaborAndRelatedExpense	82191000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	185078000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	164436000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	51469000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	43080000	USD
CY2016Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	98833000	USD
CY2017Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	84111000	USD
CY2016Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	19305000	USD
CY2016Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	19300000	USD
CY2017Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	18800000	USD
CY2017Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	18817000	USD
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	40584000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2029000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	38555000	USD
CY2016Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	43878000	USD
CY2017Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	38555000	USD
CY2016Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	19000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-18691000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-40637000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12677000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6627000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7866000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7259000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16171000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	17784000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2974000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-1795000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-11453000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-12729000	USD
CY2016Q4	us-gaap	Notes Payable Current NotesPayableCurrent	9738000	USD
CY2017Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2029000	USD
CY2017	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2015	us-gaap	Operating Expenses OperatingExpenses	152673000	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	149286000	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	139135000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	6708000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-7926000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-7086000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	14652000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	2564000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1710000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2132000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	3010000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	3046000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	2190000	USD
CY2015	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	3000000	USD
CY2016	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	2800000	USD
CY2017	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	2700000	USD
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	100000	USD
CY2015	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	31000	USD
CY2016	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	21000	USD
CY2017	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3000	USD
CY2015	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	64360000	USD
CY2016	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	54985000	USD
CY2017	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	55863000	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4409000	USD
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3347000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2356000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2476000	USD
CY2015	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
CY2016	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
CY2017	us-gaap	Paid In Kind Interest PaidInKindInterest	331000	USD
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1181000	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	934000	USD
CY2015	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	90000	USD
CY2016	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	266000	USD
CY2017	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	385000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7895000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7866000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7259000	USD
CY2012Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12686000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12678000	USD
CY2015	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2016	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2017	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	44000000	USD
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1268000	USD
CY2016	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2017	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	37000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	40000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	300000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	337000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	155000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	200000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	-1795000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-11453000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	-12729000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	80842000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	85339000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23735000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20944000	USD
CY2017Q4	us-gaap	Property Subject To Or Available For Operating Lease Number Of Units PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits	2	lease_agreement
CY2016Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	11484000	USD
CY2017Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	12494000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1400000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	700000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	7502000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	7500000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1800000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1788000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	20590000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7861000	USD
CY2015	us-gaap	Revenues Revenues	159381000	USD
CY2016	us-gaap	Revenues Revenues	141360000	USD
CY2017	us-gaap	Revenues Revenues	132049000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	5009000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	4713000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	3740000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.486
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.515
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.017
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.014
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	400000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	400000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.71
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.86
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.00
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.57
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.74
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y29D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y26D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0D
CY2015	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2016	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2017	us-gaap	Stock Issued1 StockIssued1	3302000	USD
CY2015	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-54000	USD
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	71000	USD
CY2017	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-230000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	91172000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	93856000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	86245000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	80325000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	895000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1000000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	987000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1100000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1082000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	43000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	311000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	362000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	176000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	267000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1100000	USD
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1900000	USD
CY2017Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3300000	USD
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49415000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50038000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50688000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49415000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50038000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50688000	shares
CY2017Q3	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	1000000	USD
CY2015	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	USD
CY2016	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	468000	USD
CY2017	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	1049000	USD
CY2017	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Impairment of Long-Lived Assets</font></div><div style="line-height:120%;padding-top:12px;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-lived assets are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets or intangibles may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to future undiscounted net cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.</font></div></div>
CY2017	us-gaap	Revenue Recognition Interest RevenueRecognitionInterest	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Amounts collected on trade accounts receivable are included in net cash provided by operating activities in the consolidated statements of cash flows. The Company determines the allowance for doubtful accounts by specific identification. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To the extent that required payments by the Company exceed the amount accrued, revenues in the applicable period would be reduced by the amount of the excess.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenues, Accounts Receivable, and Estimated Liability for Appeals</font></div><div style="line-height:120%;padding-top:12px;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue is recognized upon the collection of defaulted loan and debt payments. Loan rehabilitation revenue is recognized when the rehabilitated loans are sold (funded) by clients. Incentive revenue is recognized upon receipt of official notification of incentive award from customers. Under the Company’s RAC contract with CMS, the Company recognizes revenues when the healthcare provider has paid CMS for a given claim or has agreed to an offset against other claims by the provider. Providers have the right to appeal a claim and may pursue additional appeals if the initial appeal is found in favor of CMS. The Company accrues an estimated liability for appeals at the time revenue is recognized based on the Company's estimate of the amount of revenue probable of being refunded to CMS following successful appeal. In addition, if the Company's estimate of the liability for appeals with respect to revenues recognized during a prior period changes, the Company increases or decreases current period accruals based on such change in estimated liability. </font></div></div>
CY2017	us-gaap	Revenue Recognition Long Term Contracts RevenueRecognitionLongTermContracts	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Hosted Service Installation and Implementation Deliverables</font></div><div style="line-height:120%;padding-top:12px;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2008, the Company entered into a long-term contract to provide hosted services to a client beginning in March 2009. The Company determined that certain installation and implementation deliverables were not separate units of accounting within the contract, and should be combined for revenue recognition purposes with the hosted service deliverable. Accordingly, revenue for these contract elements is being taken ratably from the commencement of hosted services in March 2009 through the contract period of March 2018. Additionally, the Company deferred the direct incremental costs associated with the installation and implementation deliverables, with the costs being expensed ratably from the March 2009 commencement of services through March 2018.</font></div></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates in the Preparation of Consolidated Financial Statements</font></div><div style="line-height:120%;padding-top:12px;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the consolidated financial statements in conformity with U.S. GAAP, requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, primarily accounts receivable, intangible assets, goodwill, estimated liability for appeals, other liabilities, deferred income taxes and income tax expense, and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Our actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001550695-18-000006-index-headers.html	Edgar Link	pending
0001550695-18-000006-index.html	Edgar Link	pending
0001550695-18-000006.txt	Edgar Link	pending
0001550695-18-000006-xbrl.zip	Edgar Link	pending
a10k12312017.htm	Edgar Link	pending
ex21subsidiaries10k2017.htm	Edgar Link	pending
ex23consent10k2017.htm	Edgar Link	pending
ex311cert10k2017.htm	Edgar Link	pending
ex312cert10k2017.htm	Edgar Link	pending
ex321cert10k2017.htm	Edgar Link	pending
ex322cert10k2017.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g459986g53f80a03.jpg	Edgar Link	pending
pfmt-20171231.xml	Edgar Link	completed
pfmt-20171231.xsd	Edgar Link	pending
pfmt-20171231_cal.xml	Edgar Link	unprocessable
pfmt-20171231_def.xml	Edgar Link	unprocessable
pfmt-20171231_lab.xml	Edgar Link	unprocessable
pfmt-20171231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PHLT
Performant Healthcare Inc Stock $phlt

2017 Q4 Form 10-K Financial Statement

#000155069518000006 Filed on March 14, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHLT Performant Healthcare Inc Stock $phlt

2017 Q4 Form 10-K Financial Statement

#000155069518000006 Filed on March 14, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHLT
Performant Healthcare Inc Stock $phlt